Prof Peter Mount
Clinical (Professor)
Department of Medicine
143 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
WCN26-3998 BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE ANZDATA REGISTRY CLUSTER-RANDOMISED, SYMPTOM MONITORING WITH FEEDBACK TRIAL (SWIFT) FOR 2412 ADULTS RECEIVING FACILITY-BASED HAEMODIALYSIS
DOI: 10.1016/j.ekir.2026.1041132026
Journal article
The associations between quality of life and a five-day per week peritoneal dialysis prescription: A pilot randomized controlled study
DOI: 10.1177/089686082614321492025
Journal article
Obesity Augments Necroinflammation and Worsens Injury With Folic Acid-Induced Acute Kidney Injury
DOI: 10.1096/fj.202503440R2025
Journal article
Glycolytic control proteins in urinary extracellular vesicles are elevated during kidney transplant T cell-mediated rejection
DOI: 10.1186/s12882-025-04196-y2025
Journal article
Novel AMP-activated protein kinase activators and their potential for mitigating renal injury and fibrosis
DOI: 10.1016/j.jpet.2025.1037412025
Research grants (ARC, NHMRC, MRFF)
Renal Energy Metabolism and Obesity Related Kidney Disease
2024
Research Contracts
Consultancy Agreement for Development of Clinical Trial Protocol for Phase 1 Clinical Trial Using ProtonIntel Device
RECENT SCHOLARLY WORKS
2025
Journal article
Obesity Upregulates Necroptosis in Nephrotoxic AKI
DOI: 10.1681/asn.2025jdpcdbqc2025
Journal article
A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients
DOI: 10.1016/j.kint.2025.04.0232025
Journal article
Lessons from implementation of a nephrology key performance indicator programme
DOI: 10.1111/imj.700492025
Journal article
A pilot feasibility study of continuous cardiac output and blood pressure monitoring during intermittent hemodialysis in patients recovering from severe acute kidney injury
DOI: 10.1016/j.jcrc.2025.1550862025
Journal article
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial
DOI: 10.1093/rheumatology/keaf122